Suppr超能文献

[The results of research on the antioxidant emoksipin in clinical eye diseases].

作者信息

Egorov E A, Shvedova A A, Obraztsova I A

出版信息

Vestn Oftalmol. 1989 Sep-Oct;105(5):52-5.

PMID:2595902
Abstract

Emoxipin, a new lipid peroxidation inhibitor, has been used in the treatment of various ophthalmic diseases. The drug is characterized by a retinal-protective and an additional fibrinolytic effects; it has been effectively used to preserve the visual function in glaucoma, to treat intraocular hemorrhages and retinal injuries with physical, chemical, or bacterial factors. A manifest effect has been observed in 87% of 106 patients (118 eyes) with various ocular abnormalities. Emoxipin is recommended for the treatment of a variety of ocular diseases.

摘要

相似文献

4
[New class of drugs for treatment of eye vascular diseases].
Vestn Oftalmol. 1997 Nov-Dec;113(6):35-6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验